Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1649(1): 16-23, 2003 Jun 26.
Article in English | MEDLINE | ID: mdl-12818186

ABSTRACT

Glutathione transferases (GSTs) are a family of enzymes that detoxify electrophilic compounds, such as carcinogens or drugs, by conjugating them to glutathione. The enzymes have contributed to the understanding of protein structure, due to large differences in amino acid sequence within the family, yet similar architecture and folding. Our objective was to conduct a systematic survey of GSTP1 polymorphisms and their function. Nearly all variants detected were known polymorphisms: IVS4+13C>A; Ile105Val; Ala114Val; and g.2596T>C (Ser185Ser). However, we also found a novel Phe151Leu substitution in an African-American subject (1 out of 111). Kinetic parameters for the conjugation reaction with 1-chloro-2,4-dinitrobenzene (CDNB) were determined for the novel variant enzyme purified via heterologous expression in Escherichia coli. Five substrates were used for measurement of specific activities, including isothiocyanate compounds that occur in cruciferous vegetables (benzylisothiocyanate, phenethylisothiocyanate, and sulforaphane). Such isothiocyanate substrates are potential cancer chemopreventive agents that are conjugated by GSTs. No major change in kinetic parameters was observed. However, the half-life at 50 degrees C of the Leu 151 enzyme was reduced to 12 min, as compared to 28 min for the Phe 151 enzyme. Residue 151 is located at the N-terminus of helix alpha6 in GST motif II, surrounded by hydrophobic residues, and near the conserved "hydrophobic staple" and N-capping box motifs. These local structural elements aid in formation of helix alpha6 and promote proper folding and protein stability. Analysis of the three-dimensional structure showed that substitution of Phe 151 with Leu produces a hydrophobic cavity in the GSTP1 core, thereby destabilizing its structure. Phe151Leu represents one of the first-described allelic variations in a protein folding motif.


Subject(s)
Glutathione Transferase/chemistry , Glutathione Transferase/genetics , Isoenzymes/chemistry , Isoenzymes/genetics , Amino Acid Motifs , Amino Acid Substitution , Black People/genetics , Dinitrochlorobenzene/metabolism , Enzyme Stability/genetics , Genetic Variation , Glutathione S-Transferase pi , Glutathione Transferase/metabolism , Half-Life , Humans , Hydrophobic and Hydrophilic Interactions , Isoenzymes/metabolism , Kinetics , Leucine/genetics , Models, Molecular , Phenylalanine/genetics , Polymorphism, Genetic , Protein Folding
2.
Cancer Epidemiol Biomarkers Prev ; 11(11): 1305-15, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12433707

ABSTRACT

Prostaglandin H synthase 2 (also known as cyclooxygenase-2) is thought to play a role in the prevention of colon cancer by aspirin, an inhibitor of the enzyme. We used DNA heteroduplex analysis to screen the prostaglandin H synthase 2 gene, to search for naturally occurring enzyme variants that may simulate the effects of aspirin. We found among African-Americans a single-nucleotide polymorphism that changes valine to alanine at residue 511 (V511A; GTT>GCT; g.5939T>C; allele frequency 0.045). The polymorphism was also seen among Asian-Indians (allele frequency, 0.03) but not among Chinese, Filipinos, Hispanics, Japanese, Koreans, Samoans, and Caucasians. The amino acid change is predicted to open a 53 cubic angstrom cavity near the active site of the enzyme, but no change in V(max), K(m), or thermal stability was observed for the variant enzyme in COS-1 cell transfection assays. Case-control analysis of African-Americans from two different study populations showed a 0.56 odds ratio for colorectal adenomas among polymorphism carriers (95% confidence interval, 0.25-1.27; 161 cases and 219 controls). A similar analysis of African-Americans nested in the Multiethnic Cohort Study showed a 0.67 odds ratio for colorectal cancer (95% confidence interval, 0.28-1.56; 138 cases and 258 controls). Consistency of the results across all three of the studies is potentially compatible with a protective effect of the polymorphism, mimicking aspirin.


Subject(s)
Adenoma/enzymology , Adenoma/genetics , Black People/genetics , Colorectal Neoplasms/enzymology , Colorectal Neoplasms/genetics , Isoenzymes/drug effects , Isoenzymes/genetics , Prostaglandin-Endoperoxide Synthases/drug effects , Prostaglandin-Endoperoxide Synthases/genetics , Adenoma/epidemiology , Adolescent , Adult , Aged , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Aspirin/therapeutic use , Case-Control Studies , Codon/drug effects , Codon/genetics , Cohort Studies , Colorectal Neoplasms/epidemiology , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/therapeutic use , Female , Follow-Up Studies , Gene Frequency/drug effects , Gene Frequency/genetics , Heteroduplex Analysis , Humans , Isoenzymes/classification , Male , Membrane Proteins , Middle Aged , Polymorphism, Genetic/drug effects , Polymorphism, Genetic/genetics , Prostaglandin-Endoperoxide Synthases/classification , Risk Factors , Sequence Analysis, DNA , Sequence Analysis, Protein , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...